Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RICER in Relapsed/Refractory DLBCL
NCT01241734Phase 2Completed
- Sponsor
- Hackensack Meridian Health
- Start
- Oct 2010
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lenalidomide in diffuse large B-cell lymphoma (DLBCL), sponsored by Hackensack Meridian Health. Started Oct 2010; status: completed.
02
Drugs
lenalidomide
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT01241734.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01241734.